Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
- Status
- TERMINATED
- Phase
- PHASE2
Oral Rigosertib for Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy
- Status
- COMPLETED
- Phase
- NA
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
The Head and Neck Tumor Biobank
- Status
- COMPLETED
- Phase
- N/A
Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- NA
Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3
Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy Study of Temsirolimus to Treat Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3